Datscan vs Striascan: Side-by-Side Comparison
Quick answer: Datscan and Striascan are both radiopharmaceutical diagnostic agent (dopamine transporter imaging) used for similar indications. They share a mechanism of action but differ in dosing, half-life, side-effect profile, and clinical preferences. Switching between them is a clinical decision.
Side-by-side comparison
| Feature | Datscan | Striascan |
|---|---|---|
| Drug class | Radiopharmaceutical diagnostic agent (dopamine transporter imaging) | Radiopharmaceutical diagnostic agent (dopamine transporter imaging) |
| ATC code | V09AB | V09AB03 |
| Primary indications | Differential diagnosis of parkinsonian syndromes, Differential diagnosis of dementia with Lewy bodies | Differential diagnosis of parkinsonian syndromes, Suspected dementia with Lewy bodies |
| Mechanism | Ioflupane (123I) binds to striatal dopamine transporters, allowing SPECT visualization of presynaptic dopaminergic neurons | Iodine-123 labeled cocaine analog that binds presynaptic dopamine transporters in the striatum for SPECT imaging |
| Common dose | 111-185 MBq IV single dose | 111-185 MBq intravenous injection |
| Detail page | Datscan details → | Striascan details → |
How to choose between Datscan and Striascan
Both medicines belong to the same therapeutic class and address overlapping indications. Selection between them depends on:
- Patient-specific factors: age, kidney and liver function, other medications, allergies, comorbidities
- Specific clinical indication: some class members are preferred for particular conditions or guideline recommendations
- Dosing preference: once-daily vs twice-daily, oral vs injectable, food requirements
- Tolerability: individual side-effect profiles vary even within a class
- Drug interactions: patient's other medications may interact differently with each option
- Cost and availability: generic availability, insurance coverage, regional access
Should you switch?
Switching between class members is a clinical decision, not a self-help one. Reasons your prescriber may consider switching include:
- Inadequate response to current medication
- Side effects affecting quality of life
- New drug interactions due to a recently added medication
- Cost or availability changes
- Updated guidelines favoring a different option
Never switch medications, change dose, or stop without consulting your prescriber.
Related
All Radiopharmaceutical diagnostic agent (dopamine transporter imaging) on iMedic · Datscan full details · Striascan full details
Frequently asked questions
Is Datscan better than Striascan?
Neither is universally 'better.' They are both radiopharmaceutical diagnostic agent (dopamine transporter imaging) with similar mechanisms of action. The right choice depends on the specific clinical situation, patient factors, dosing preferences, drug interactions, and tolerability. Discuss with your prescriber.
Can I switch from Datscan to Striascan?
Switching is possible but should be done under clinical supervision. Different class members may not be interchangeable on a 1:1 dose basis, and tapering or transition strategies vary. Never switch on your own.
Do Datscan and Striascan have the same side effects?
They share class-wide side-effect tendencies but differ in individual profiles. Some patients tolerate one better than the other. Specific frequency and severity of side effects can be found on each medicine's individual page.
Are Datscan and Striascan available as generics?
Generic availability depends on patent status in your country. Most well-established class members are available generically and are clinically equivalent to brand-name versions.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.